Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease
Claudio Liguori, Agostino Chiaravalloti, Giuseppe Sancesario, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2016) Vol. 43, Iss. 11, pp. 2040-2049
Closed Access | Times Cited: 95

Showing 26-50 of 95 citing articles:

Lactylation in CNS disorders: mechanisms, cellular function, and disease relevance
Jiaxin Tian, Tongyu Zhang, Ruidan Zhang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
Stefan L.C. Geijselaers, Pauline Aalten, Inez H.G.B. Ramakers, et al.
Journal of Alzheimer s Disease (2017) Vol. 61, Iss. 1, pp. 309-320
Open Access | Times Cited: 39
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer’s disease patients: A CSF and FDG PET study
Agostino Chiaravalloti, Gaetano Barbagallo, Maria Ricci, et al.
Brain Research (2017) Vol. 1678, pp. 116-122
Open Access | Times Cited: 37
When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
Claudio Liguori, Mariangela Pierantozzi, Agostino Chiaravalloti, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 34
Redox signaling and Alzheimer’s disease: from pathomechanism insights to biomarker discovery and therapy strategy
Yuanyuan Chen, Minchang Wang, Yanni Wang, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Universal Glia to Neurone Lactate Transfer in the Nervous System: Physiological Functions and Pathological Consequences
Carolyn L. Powell, Anna R. Davidson, Angus M. Brown
Biosensors (2020) Vol. 10, Iss. 11, pp. 183-183
Open Access | Times Cited: 29
Geriatric Depression and Cognitive Impairment—An Update
Shiva Shanker Reddy Mukku, Ajit Bhalchandra Dahale, Nagalakshmi Rajavoor Muniswamy, et al.
Indian Journal of Psychological Medicine (2021) Vol. 43, Iss. 4, pp. 286-293
Open Access | Times Cited: 25
Metabolomics in degenerative brain diseases
Melissa Escobar Quintero, João Guilherme de Moraes Pontes, Ljubica Tasić
Brain Research (2021) Vol. 1773, pp. 147704-147704
Open Access | Times Cited: 25
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late‐onset epilepsy of unknown aetiology: A prospective study
Mariana Fernandes, Natalia Manfredi, Lavinia Aluisantonio, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5384-5396
Closed Access | Times Cited: 18
Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation
Sai Sanwid Pradhan, Thota Sai Manohar, R. Saiswaroop, et al.
Disease Models & Mechanisms (2022) Vol. 15, Iss. 10
Open Access | Times Cited: 18
Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary 18F-FDG PET/CT Study
Riccardo Camedda, Chiara Giuseppina Bonomi, Martina Gaia Di Donna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 751-751
Open Access | Times Cited: 9
Potential Metabolite Biomarkers of Multiple Sclerosis from Multiple Biofluids
Fatema Bhinderwala, Heidi E. Roth, Mary L. Filipi, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 6, pp. 1110-1124
Closed Access | Times Cited: 3
Lactate/Hydroxycarboxylic Acid Receptor 1 in Alzheimer’s Disease: Mechanisms and Therapeutic Implications-Exercise Perspective
Xiangyuan Meng, Weijia Wu, Yingzhe Tang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7717-7731
Closed Access | Times Cited: 3
Regulation of Glycolysis-Derived L-lactate Production in Astrocytes Rescues the Memory Deficits and Aβ Burden in Early Alzheimer’s Disease Models
Xiu Yang, Yuan-Hao Chen, Le Liu, et al.
Pharmacological Research (2024) Vol. 208, pp. 107357-107357
Open Access | Times Cited: 3
Diagnosis of neurodegenerative dementia: where do we stand, now?
Giulia Maria Sancesario, Sergio Bernardini
Annals of Translational Medicine (2018) Vol. 6, Iss. 17, pp. 340-340
Open Access | Times Cited: 29
Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far‐reaching implications for neurological disorders
Chiara Berteotti, Claudio Liguori, Marta Pace
European Journal of Neuroscience (2020) Vol. 53, Iss. 4, pp. 1136-1154
Closed Access | Times Cited: 25
Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer’s Disease Biomarkers
Mariana Fernandes, Agostino Chiaravalloti, Natalia Manfredi, et al.
Journal of Alzheimer s Disease (2022) Vol. 88, Iss. 1, pp. 127-139
Closed Access | Times Cited: 15
Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?
Alessandro Di Stefani, Mariangela Pierantozzi, Silvia Cardarelli, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 14
Amyloid-β42 stimulated hippocampal lactate release is coupled to glutamate uptake
Erin R. Hascup, Lindsey N. Sime, Mackenzie R. Peck, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment
Hideo Hagihara, Hirotaka Shoji, Satoko Hattori, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 8
Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences
Timothy M. Baran, Feng Lin
Journal of Alzheimer s Disease (2018) Vol. 66, Iss. 1, pp. 307-318
Open Access | Times Cited: 27
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology
Claudio Liguori, Agostino Chiaravalloti, Francesca Izzi, et al.
Brain (2017) Vol. 140, Iss. 12, pp. e75-e75
Open Access | Times Cited: 25
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study
Claudio Liguori, Roberta Ruffini, Enrica Olivola, et al.
Parkinsonism & Related Disorders (2019) Vol. 64, pp. 97-105
Closed Access | Times Cited: 24
Contrasting Metabolic Insufficiency in Aging and Dementia
Dennis A. Turner
Aging and Disease (2021) Vol. 12, Iss. 4, pp. 1081-1081
Open Access | Times Cited: 20
Lactate metabolism and histone lactylation in the central nervous system disorders: impacts and molecular mechanisms
Yao Wang, Ping Li, Yuan Xu, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2

Scroll to top